Long suffering from diseases of the kidneys, bladder, and liver, Baltes was unable to attend the Third Plenary Council of Baltimore in 1884 due to ill health.
The money raised supports patient care and research in pediatric kidney and urinary tract diseases and disorders.
Blisibimod, an investigational anti-BAFF molecule in Phase III trails for the treatment of systemic lupus erythematosus and Phase II trials for the treatment of IgA nephropathy.
Complement factor H-related protein 5 (CFHR5) nephropathy (also known as Troodos nephropathy) is a form of inherited kidney disease which is endemic in Cyprus and is caused by a mutation in the gene CFHR5.
The disease was originally called "Vratsa nephritis," and became known as "Balkan endemic nephropathy" later, after people living in Yugoslavia and Romania were found to be suffering from it as well.